MUSTANG BIO, INC. Increase (Decrease) in Other Current Assets
MUSTANG BIO, INC. (MBIO) reported Increase (Decrease) in Other Current Assets of $50.00 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2018-11-13
- 2018-09-30: Increase (Decrease) in Other Current Assets 9 month $50.00K.
- 2017-09-30: Increase (Decrease) in Other Current Assets 9 month $0.00.
| Period end | Increase (Decrease) in Other Current Assets 9 month |
|---|---|
| 2018-09-30 | $50.00K 10-Q · filed 2018-11-13 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |